Seock‐Ah Im
Seoul National University(KR)Cancer Research Institute(US)Seoul National University Hospital(KR)National University College(PR)Korea Research Institute of Bioscience and Biotechnology(KR)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, PARP inhibition in cancer therapy
Most-Cited Works
- → Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer(2018)4,261 cited
- → Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation(2017)3,123 cited
- → Palbociclib and Letrozole in Advanced Breast Cancer(2016)2,879 cited
- → Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer(2011)2,495 cited
- → Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer(2022)2,394 cited
- → Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial(2011)2,311 cited